Lael Stone
Overview
Explore the profile of Lael Stone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mehanna R, Stone L, Itin I
Clin Park Relat Disord
. 2021 Jul;
1:74-76.
PMID: 34316605
Movement disorders in demyelinating diseases can be coincidental or secondary to a demyelinating lesion. We here report the first case of coincidental association of neurosarcoidosis and idiopathic Parkinson's disease.
2.
Koenig K, Beall E, Sakaie K, Ontaneda D, Stone L, Rao S, et al.
PLoS One
. 2021 Jun;
16(6):e0251338.
PMID: 34101741
Cognitive impairment is a common symptom in individuals with Multiple Sclerosis (MS), but meaningful, reliable biomarkers relating to cognitive decline have been elusive, making evaluation of the impact of therapeutics...
3.
Domingo S, Kinzy T, Thompson N, Gales S, Stone L, Sullivan A
Int J MS Care
. 2018 Aug;
20(4):191-197.
PMID: 30150904
Background: Sexual dysfunction is a common symptom of multiple sclerosis (MS) that often goes unreported by both the patient and the clinician. Sexual dysfunction can affect a person's mood, relationships,...
4.
Koenig K, Rao S, Lowe M, Lin J, Sakaie K, Stone L, et al.
Mult Scler
. 2018 Mar;
25(4):574-584.
PMID: 29512427
Background: Episodic memory loss is one of the most common cognitive symptoms in patients with multiple sclerosis (MS), but the pathophysiology of this symptom remains unclear. Both the hippocampus and...
5.
LaGanke C, Samkoff L, Edwards K, Jung Henson L, Repovic P, Lynch S, et al.
Neurol Neuroimmunol Neuroinflamm
. 2017 Jun;
4(4):e367.
PMID: 28642891
Objective: To evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of VX15/2503 in a randomized, single-dose, dose-escalation, double-blind, placebo-controlled study enrolling adult patients with MS. Methods: Single IV doses...
6.
Koenig K, Sakaie K, Lowe M, Lin J, Stone L, Bermel R, et al.
Mult Scler
. 2015 Jun;
21(14):1794-801.
PMID: 26106010
Background: Imaging can provide noninvasive neural markers of disease progression in multiple sclerosis (MS) that are related to behavioral and cognitive symptoms. Past work suggests that diffusion tensor imaging (DTI)...
7.
Isobe N, Madireddy L, Khankhanian P, Matsushita T, Caillier S, More J, et al.
Brain
. 2015 Mar;
138(Pt 6):1518-30.
PMID: 25818868
The aims of this study were: (i) to determine to what degree multiple sclerosis-associated loci discovered in European populations also influence susceptibility in African Americans; (ii) to assess the extent...
8.
Lowe M, Koenig K, Beall E, Sakaie K, Stone L, Bermel R, et al.
Brain Connect
. 2014 Aug;
4(7):558-65.
PMID: 25117651
This work presents a pathway-dependent anatomic and functional connectivity analysis in 19 patients with relapse-remitting multiple sclerosis (MS) and 16 age-, education-, and gender-matched controls. An MS population is used...
9.
Koenig K, Sakaie K, Lowe M, Lin J, Stone L, Bermel R, et al.
Magn Reson Imaging
. 2014 Feb;
32(4):354-8.
PMID: 24512796
Purpose: To assess for associations between hippocampal atrophy and measures of cognitive function, hippocampal magnetization transfer ratio (MTR), and diffusion measures of the fornix, the largest efferent white matter tract...
10.
Tavee J, Rensel M, Planchon S, Butler R, Stone L
Int J MS Care
. 2014 Jan;
13(4):163-8.
PMID: 24453721
The objective of this study was to determine whether meditation affects pain and quality of life in people with multiple sclerosis (MS) and peripheral neuropathy (PN). A total of 22...